Lilly’s Jaypirca just beat out AbbVie’s Imbruvica in a direct showdown for treating certain blood cancers. Jaypirca helped more patients see their cancer shrink or disappear, and early signs suggest it might even help people stay healthier longer. The best part? It works for both newbies and those who’ve already had other treatments. Big win for Lilly—and maybe for future patients, too! #Health #BodyHealth #CancerResearch